Subsequent scratch assays and Transwell matrigel invasion assays revealed that ABI3 downregulation notably attenuated the migratory and invasive capabilities of SHG44 and U251 glioma cells (Figures 13A–C). The gene discussed is ABI3; the disease is central nervous system cancer.